Evan A. Thackaberry's most recent trade in Vigil Neuroscience Inc was a trade of 65,000 Stock Option Grant (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Vigil Neuroscience Inc | Evan A. Thackaberry | SVP, Head of Early Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 65,000 | 65,000 | - | - | Stock Option Grant (Right to Buy) | |
Vigil Neuroscience Inc | Evan A. Thackaberry | SVP, Head of Early Development | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 05 May 2022 | 1,500 | 1,500 | - | 4 | 6,000 | Common Stock |
Vigil Neuroscience Inc | Evan A. Thackaberry | SVP, Head of Early Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 45,000 | 45,000 | - | - | Stock Option Grant (Right to Buy) |